RxDoctor Payments Data

Melissa Ricci, DPM

Podiatrist · Milton, MANPI 1598117350

Payments from drug & device makers

What this record shows

This record is dominated by other: $37,708 of the $46,337 with a category attached, or 81.4%. Convatec Inc. accounts for 81.9% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $38,477, more than ten times the $2,196 reported in 2019. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,337in general payments, 2019–2025

Across 252 payments — averaging $183.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$38K
  • Smith+Nephew$2K
  • Triad Life Sciences Inc.$2K
  • Stryker$730
  • Paratek Pharmaceuticals, Inc.$662
  • Amgen$638
  • plus $3K from 25 others

What the payments were for

  • Travel & lodging$1,5273%
  • Food & beverage$7,10315%
  • Other$37,70881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,337 in reported general payments places this provider in the 95th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$310,531
Medicare patients
442
Services billed
4,480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole59$1,403
Cefadroxil22$99
Doxycycline Hyclate11$51

Paid to pharmacies, not to this prescriber.

Other podiatrist in Milton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →